— Kerastem STYLE phase II clinical trial results update. Somewhat positive news of 17 percent increase in hair count at 6 months post-treatment. However, they only treated men in the early stages of hair loss (Norwood Scale I to III).
— Reader “omg” posted an interesting link to a study from Taiwan with a great title: “Never too old to regenerate (hair)”. The researchers report on an 80 year old man who regrew 1 brand new pigmented black hair after scalp wounding due to excision of a basal cell carcinoma. Yet more evidence in support of wounding, the main idea behind the work of well known company Follica. The new (or regenerated old) hair remained black at the 42-month time of follow-up. I do not think the claim that the researchers make that this is the world’s first case of wounding led hair growth in human skin is true.
— A potential improvement in current hair regeneration technology from Japan via self-sorted hair follicle germs (ssHFGs). I visualize an image of ant collaboration (which creeps me out a bit), each time I read that term. Dr. Junji Fukuda who I have covered on this blog before is a lead author. Update: A new article on this development came out on February 1, 2018.
— Dr. Takashi Tsuji was back in the news a couple of weeks ago. He is leading a Japanese team that includes RIKEN researchers that will develop technology to analyze human health ramifications of changes in people’s hair shape and quality. According to Dr. Tsuji, some research indicates that certain changes in human hair components are unique to people with diseases such as cancer and diabetes. Perhaps in future one can detect cancer earlier depending on hair analysis.
— Discussion about Donald Trumps’s hair never seems to get old when it comes to the major newspapers. I previously discussed Mr. Trump’s usage of Finasteride as well as a 10 page detailed article on his hair. Now come news that his daughter Ivanka has claimed that Donald Trump has had scalp reduction surgery.
— Topical Tofacitinib 2% ointment at least moderately effective in 3 of 10 patients suffering from alopecia areata. Dr. Brett King led the study. Hopefully, Aclaris will see better results for male pattern hair loss sufferers with their topical JAK product when it finally comes out. Fingers crossed.